Krebs Biochemicals (India) Probability of Future Stock Price Finishing Under 73.41
| KREBSBIO | 107.80 2.37 2.15% |
Krebs |
Krebs Biochemicals Target Price Odds to finish below 73.41
The tendency of Krebs Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 73.41 or more in 90 days |
| 107.80 | 90 days | 73.41 | about 8.87 |
Based on a normal probability distribution, the odds of Krebs Biochemicals to drop to 73.41 or more in 90 days from now is about 8.87 (This Krebs Biochemicals and probability density function shows the probability of Krebs Stock to fall within a particular range of prices over 90 days) . Probability of Krebs Biochemicals and price to stay between 73.41 and its current price of 107.8 at the end of the 90-day period is about 86.72 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 2.01 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Krebs Biochemicals will likely underperform. Additionally Krebs Biochemicals and has an alpha of 0.2891, implying that it can generate a 0.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Krebs Biochemicals Price Density |
| Price |
Predictive Modules for Krebs Biochemicals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Krebs Biochemicals and. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Krebs Biochemicals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Krebs Biochemicals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Krebs Biochemicals is not an exception. The market had few large corrections towards the Krebs Biochemicals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Krebs Biochemicals and, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Krebs Biochemicals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.29 | |
β | Beta against Dow Jones | 2.01 | |
σ | Overall volatility | 11.25 | |
Ir | Information ratio | 0.09 |
Krebs Biochemicals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Krebs Biochemicals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Krebs Biochemicals and can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Krebs Biochemicals had very high historical volatility over the last 90 days | |
| The company reported the revenue of 504.21 M. Net Loss for the year was (197.28 M) with profit before overhead, payroll, taxes, and interest of 244.19 M. | |
| About 78.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: This Stock Surges 26.5 percent in a Week A Lesson in Staying Ahead with InvestingPro By Investing.com - Investing.com India |
Krebs Biochemicals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Krebs Stock often depends not only on the future outlook of the current and potential Krebs Biochemicals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Krebs Biochemicals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.6 M | |
| Cash And Short Term Investments | 1.4 M |
Krebs Biochemicals Technical Analysis
Krebs Biochemicals' future price can be derived by breaking down and analyzing its technical indicators over time. Krebs Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Krebs Biochemicals and. In general, you should focus on analyzing Krebs Stock price patterns and their correlations with different microeconomic environments and drivers.
Krebs Biochemicals Predictive Forecast Models
Krebs Biochemicals' time-series forecasting models is one of many Krebs Biochemicals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Krebs Biochemicals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Krebs Biochemicals and
Checking the ongoing alerts about Krebs Biochemicals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Krebs Biochemicals and help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Krebs Biochemicals had very high historical volatility over the last 90 days | |
| The company reported the revenue of 504.21 M. Net Loss for the year was (197.28 M) with profit before overhead, payroll, taxes, and interest of 244.19 M. | |
| About 78.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: This Stock Surges 26.5 percent in a Week A Lesson in Staying Ahead with InvestingPro By Investing.com - Investing.com India |
Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.